Nuno Mendonça
Directeur Technique/Scientifique/R&D chez AC IMMUNE SA
Fortune : 18 835 $ au 30/04/2024
Provenance du réseau au premier degré de Nuno Mendonça
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
21
| Public Company | Pharmaceuticals: Major | 21 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Nuno Mendonça via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
Glenmark Pharmaceuticals Inc., USA
 Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Pharmaceuticals USA, Inc. manufactures, markets, and distributes generic pharmaceutical products. It offers campral delayed-release tablets, differin gel, aclovate cream, aclovate topical ointment, ortho novum, and other related products. The company was founded in 2003 and is headquartered in Mahwah, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Abiogen Pharma SpA
 Abiogen Pharma SpA Miscellaneous Commercial ServicesCommercial Services Abiogen Pharma SpA manufactures and develops pharmaceutical products. The firm offers therapeutic drugs in the anti-inflammatory and painkiller, respiratory, bone metabolism, and dermatology areas. The company was founded by Massimo di Martino in 1997 and is headquartered in Pisa, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Schweizerische Management Gesellschaft | Director/Board Member | ||
| SWISS LIFE HOLDING AG | Life/Health Insurance | Director/Board Member | |
| Suva City Council | Corporate Officer/Principal | ||
HUBER+SUHNER (UK) Ltd.
 HUBER+SUHNER (UK) Ltd. Electronic Production EquipmentElectronic Technology HUBER+SUHNER (UK) Ltd. manufactures, imports, and sells electrical and optical connectivity components and accessories. It offers radio frequency and fiber optic products including antennas, assemblies, cables, connectors and adapters, lightning and EMP protectors, and resistive components. The company was founded on March 30, 1967 and is headquartered in Bicester, the United Kingdom. | Electronic Production Equipment | Director/Board Member | |
| Max Schmidheiny-Stiftung | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Gebert Rüf Stiftung | Corporate Officer/Principal | ||
| University of Tilburg | College/University | Corporate Officer/Principal | |
| Richard Büchner Foundation | Director/Board Member | ||
| Swiss Society of Economics & Statistics | President | ||
| Swiss Institute For Intl Economics & Applied Economic Research | Chairman | ||
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| Institute of Public Finance & Fiscal Law | Corporate Officer/Principal | ||
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
| University of Zurich | College/University | Undergraduate Degree | |
| University of Bern | College/University | Undergraduate Degree | |
| Swiss Institute for Empirical Economic Research | Director/Board Member | ||
| University of St. Gallen | College/University | Corporate Officer/Principal | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
| University of Milan | College/University | Doctorate Degree | |
| Technical Institute of Jiangsu | College/University | Undergraduate Degree | |
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Biotechnology | Founder | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| École Polytechnique Fédérale de Lausanne | College/University | Doctorate Degree | |
| Goizueta Business School-Emory | College/University | Undergraduate Degree | |
| Msizi Africa | Director/Board Member | ||
| Ernst & Young SA (Geneva) | Corporate Officer/Principal | ||
| University of Lancaster | College/University | Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ViiV Healthcare Co. | Corporate Officer/Principal | ||
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Executive Officer | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Oxford University Medical School | College/University | Doctorate Degree | |
| Business School Lausanne | College/University | Masters Business Admin | |
| University of Belgrade | College/University | Undergraduate Degree | |
| Centre for International Intellectual Property Studies | College/University | Graduate Degree |
Statistiques
Internationale
| Suisse | 26 |
| Etats-Unis | 8 |
| Royaume-Uni | 5 |
| Italie | 3 |
| Pays-Bas | 3 |
Sectorielle
| Consumer Services | 16 |
| Health Technology | 12 |
| Finance | 3 |
| Electronic Technology | 3 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 50 |
| Corporate Officer/Principal | 44 |
| Chief Tech/Sci/R&D Officer | 17 |
| Independent Dir/Board Member | 15 |
| Doctorate Degree | 13 |
Relations les plus connectées
| Insiders | |
|---|---|
| Monika Bütler | 25 |
| Douglas Williams | 25 |
| Werner Lanthaler | 13 |
| Andrea Pfeifer | 11 |
| Carl June | 9 |
| Monica Shaw | 8 |
| Gary Waanders | 8 |
| Marie Kosco-Vilbois | 7 |
| Sonia Maria Poli | 7 |
| Roy Ervin Twyman | 6 |
| Julien Rongère | 5 |
| Madiha Derouazi | 5 |
| Piergiorgio Donati | 5 |
| Alexandre Caratsch | 4 |
| Oliver Sol | 4 |
- Bourse
- Insiders
- Nuno Mendonça
- Connexions Sociétés
